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Cytochalasin B binding to rabbit proximal tubular basolateral mem-
branes. Cytochalasin B binds to the Na*independent D-glucose trans-
porter in non-renal tissues. We have shown previously that the Na-
independent D-glucose transporter of the rabbit renal proximal tubular
cell is localized exclusively in the basolateral membrane. To determine
whether cytochalasin B binds to this renal transporter we measured
binding of [3Hlcytochalasin B to proximal tubular basolateral mem-
branes isolated from rabbit kidneys. A steady state of binding is reached
by IS minutes at 20°C over a concentration range of 0.01 to 50 M.
Non-linear regression analysis of cytochalasin B binding from 0.01 to 20
g plotted according to Scatchard reveals two classes of binding sites
with Kd 5.88 x I0 si, Bmax 16.1 pniol/mg protein; and Kd 5.62 X l0-
M, 2816 pmol/mg protein. [3H}cytochalasin B (0.1 .tM) binding to
basolateral membranes is a reversible process; it is displacable by
excess unlabeled cytochalasin B with a time course similar to binding of
[1H]cytochalasin B. Binding of [3Hlcytochalasin B is inhibited by 500
mM D-glucose (21%), 2-deoxy-D-glucose (57%) and 3-O-methyl-D-
glucose (64%), but not by L-glucose. [3H]cytochalasin B binding is
reduced 71% by 0.1 msi phloretin, but only 26% by 0.1 mt phlorizin.
Such substrate specificity and inhibitor sensitivity are similar to those
previously demonstrated in non-renal tissues by others as well as in
rabbit renal proximal tubular basolateral membranes by us. Our data
suggest that cytochalasin B binds to the Na-independent D-glucose
transporter or a component of the transporter in the renal proximal
tubular basolateral membrane.
The renal proximal tubular cell is a polar epithelial cell, the
luminal and antiluminal membranes of which serve different
transport functions. Reabsorption of D-glucose from glomerular
ultrafiltrate to peritubular capillary blood is effected through the
activities of two different types of transporters. D-glucose
crosses the luminal brush border membrane through the action
of a Natdependent co-transporter and enters the blood across
the antiluminal basolateral membrane via a Na-independent
transporter. Each of these processes has been characterized in
membrane vesicles isolated from proximal tubular cells. Data
reported from a number of laboratories [1—3], including our own
[4], have shown that the luminal and antiluminal D-glucose
transporters differ not only in their Na-dependency but also in
their substrate specificity and inhibitor sensitivity. Thus, the
two hexose analogues, 2-deoxy-D-glucose and 3-0-methyl-
D-glucose are substrates only for the antiluminal D-glucose
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transporter but not the luminal Nat-glucose co-transporter.
Phlorizin at 10 M inhibits the luminal, but not the antiluminal
transporter, while phloretin and cytochalasin B, a compound
isolated from the mold Helminthosporin dematioideum, at the
same concentration are inhibitory to the antiluminal, but not the
luminal D-glucose transport.
The lack of Na-dependency, the substrate specificity, and
sensitivity to cytochalasin B of the antiluminal D-glucose trans-
porter are similar to characteristics described for Na-indepen-
dent transporters in non-polar cells such as erythrocytes [5—7],
adipocytes [8, 9], and in the basolateral membrane of the polar
intestinal enterocyte [10, 11]. Cytochalasin B binds to multiple
sites in membranes prepared from these cells. Binding to sites
of the highest affinity correlates with inhibition of D-glucose
transport. These sites are thought to correspond to the Na-
independent D-glucose transporter itself, or to a component of
the transporter [5—9]. Binding of cytochalasin B to high affinity
receptors in membranes prepared from erythrocytes and adi-
pocytes has been a useful tool for characterization of Na-
independent D-glucose transport activity.
Silverman has reported preliminary data that show binding of
cytochalasin B to basolateral membranes prepared from dog
kidney [121. Binding to multiple sites was suggested, however,
details such as kinetic constants relating to binding were not
presented. Accordingly, the present studies were conducted to
further characterize the binding of cytochalasin B to isolated
proximal tubular basolateral membranes. Our data are similar
to findings in non-renal cell membranes and are consistent with
the identity of the high-affinity cytochalasin B binding site in
proximal tubular basolateral membranes as the Na-indepen-
dent D-glucose transporter, or a component of the transporter.
Methods
Basolateral membranes from kidneys of female New Zealand
White rabbits (2.5 kg) were used in these experiments. The
kidneys were removed surgically following pentobarbital-in-
duced anaesthesia and basolateral membranes prepared exactly
as previously described using a Percoll density gradient ultra-
centrifugation technique. A complete enzymatic characteriza-
tion of this preparation has been published [4]. Enrichment for
activity of the basolateral membrane marker enzyme, Na*Kf
ATPase, in basolateral membrane suspensions over activity in
cortex homogenates is approximately 17-fold. Parathyroid hor-
mone-stimulated adenylate cyclase activity of the basolateral
membrane is enhanced 6.8-fold over that of crude homogenate
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which is consistent with the proximal tubular origin of the
preparation [4]. During the last two centrifugations of the
isolation procedure, basolateral membranes were suspended in
a Krebs-Ringers phosphate buffer containing 125 mM NaCI, 5
mM KCI, 1.5 mri CaCl2, 1.2 mivi MgSO4, and 10 mt Na2HPO4
at pH 7.5. Membranes were stored at —70°C and thawed
immediately prior to use in experiments.
Binding of [4-3H] cytochalasin B (18.5 Ci/mmol, New En-
gland Nuclear, Boston, Massachusetts, USA) to isolated baso-
lateral membranes was measured using a rapid centrifugation
technique. Basolateral membranes were suspended in 100 1d of
Krebs-Ringers phosphate buffer containing 0.1% bovine serum
albumin (to reduce "background" radioactivity), [3HJcytochal-
asin B (10,000 to 60,000 cpm) and varying concentrations of
unlabeled cytochalasin B. Within a given series of experiments,
either 0.05 or 0.10 mg of protein was used. Binding of
[3H]cytochalasin B, as expressed in pmol/mg protein, is unaf-
fected by the amount of membrane protein present in the
incubation medium over this range. Cytochalasin B was dis-
solved in ethanol such that the final concentrations of ethanol in
the suspensions were 0.4 to 1.0%. Within a given series of
experiments, the concentration of ethanol was always the same.
Binding assays were performed in triplicate in 1.5 ml polypro-
pylene Eppendorf tubes. Following incubation at 10°C for
varying periods of time, tubes were centrifuged for one minute
in a Beckman microfuge (Beckman Instruments, Fullerton,
California, USA). Supernatants containing unbound radioactiv-
ity were discarded and the remaining membrane pellets were
solubilized in 100 M' of 1.5% sodium-dodecyl sulfate. Radioac-
tivity in solubilized pellets was counted using liquid scintillation
spectrometry. The recovery of basolateral membrane protein
from the pellets was approximately 65% for both 0.05 mg and
0.10mg samples. Data are expressed as binding per mg protein
(measured for each experiment) and reflect protein present in
pellets. Identical experiments were performed in the absence of
basolateral membranes to determine background radioactiv-
ities. Aqueous space within the membrane pellets was deter-
mined by measuring [fructose-l-3H(N)-sucrose (11.4 Ci/mmol,
New England Nuclear) "trapped" within pellets for each ex-
periment. Measurements of [3H]cytochalasin B bound to mem-
branes were corrected for both background radioactivity (4.4%
of total) and "trapped" radioactivity (1.2% of total). Protein
measurements were made by the method of Lowry et al [13]
using bovine serum albumin as a standard.
Results
Binding of 0.01, 0.1 and 50 MM [3H]cytochalasin B to baso-
lateral membranes was determined as a function of time of
incubation at 20°C. At each concentration, a steady state of
binding was reached by 15 minutes of incubation (Fig. I).
Accordingly, binding of [3H]cytochalasin B measured at IS
minutes was used to reflect steady state binding in subsequent
experiments.
Steady state binding to basolateral membranes of varying
concentrations of cytochalasin B (0.01 to 20 MM) were plotted
according to Scatchard (Fig. 2). Non-linear regression analysis
of data was conducted using an interactive computer program in
order to isolate all binding sites as described by Munson and
Rodbard [14]. The result of such analysis is most compatible
with a two-binding site model: K 5.88 x lO_8 M. 16.1
pmol/mg protein; and Kd 5.62 x IO M, Bmax 2816 pml/mg
protein (N 3). No concentration-independent non-specific
binding component was identified which confirms the adequacy
of correction for background and "trapped" radioactivities.
For all subsequent binding experiments, the concentration of
0.1 MM [3H]cytochalasin B was used as this approximates the
K of the high affinity site. At this concentration, the occupancy
of the high affinity binding site is estimated to be 59% while that
of the second site is 0.1%.
To determine whether binding of [5H]cytochalasin B to
basolateral membranes is a reversible process, 10 MM unlabeled
cytochalasin B was added to membranes that had been equili-
brated with 0.1 MM [1H]cytochalasin B and binding of radioac-
tivity to membranes was measured over time following addi-
tion. As a control, an equal volume of ethanol-containing buffer
was added. As shown in Figure 3, "displacement" of
[3H]cytochalasin B was reversible with a time course similar to
that of binding. Maximal displacement was attained by IS
minutes following addition of unlabeled cytochalasin B.
The effect of varying concentrations of known glucose trans-
port inhibitors, phlorizin, phloretin, cytochalasin B, and its
analogue cytochalasin E, on steady state binding of 0.1 MM
13H]cytochalasin B to basolateral membranes is illustrated in
Figure 4. Data are expressed as percent [3H]cytochalasin B
bound in the presence of inhibitor divided by that in the absence
of inhibitor (B/Bo). Binding of [3H]cytochalasin B is inhibited
more completely by phloretin than by phlorizin. Thus binding is
reduced 71 16% by io— M phloretin (N 4, P < 0.01 by
Dunnett's multiple comparison procedure [15]), but only 26
10% by the same concentration of phlorizin (P = NS).
[3H]cytochalasin B binding is inhibited to a greater extent by
cytochalasin E and by unlabeled cytochalasin B itself than by
either phlorizin or phloretin.
In order to ascertain whether binding of [3H]cytochalasin B
to basolateral membranes is affected by D-glucose or hexose
analogues, we measured binding of 0.1 MM [3H]cytochalasin B
in the presence of 500 mrvi L-glucose, D-glucose, 2-deoxy-
D-glucose or 3-O-methyl-D-glucose. In preliminary experi-
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Fig. 1. Binding of [3HJcvtochalasin B to renal basolateral membranes
as a function of time of incubation. Data are expressed as the ratio of
[3Hlcytochalasin B cpm bound/total cpm added to incubations and
represent the mean SE of 3 experiments. Symbols are: (D 0.01 /SM;
(A) 0.1 ,sM; (0) 50 tM.
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Fig. 3. Binding of [3HJcytochalasin B (0.! M) to basolateral mem-
branes as a function of time of incubation. Data are expressed as the
ratio of 13H]cytochalasin B cpm bound/total cpm added to incubations
and represent the mean SE of 3 experiments. Symbols are: (U)
control; (A) 10 M Cyto B.
ments we determined that binding was not affected by 500 mi
L-glucose (12.9 0.7 vs. 12.9 1.1. pmol/mg protein, N = 4,
P = NS). However, as shown in Figure 5, binding is signifi-
cantly inhibited by 500 mrvi D-glucose (P < 0.01), 2-deoxy-
D-glucose (P < 0.01), and 3-O-methyl-D-glucose (P < 0.01)
(Dunnett's multiple comparison procedure) in comparison with
L-glucose. The magnitude of inhibition by D-glucose (21 3%)
is less than that effected by 2-deoxy-D-glucose (57 2%) or by
3-O-methyl-D-glucose (64 1%).
Discussion
The exit of D-glucose across the basolateral membrane of the
renal proximal tubular cell occurs through the activity of a
Na-independent transporter [12]. The Na'-independent na-
Concentration, M
Fig. 4. Binding qf /3HJcytocI,alasin B (0.1 p.s) to basolateral mem-
branes. Data are expressed as mean SE of 4 experiments. Symbols
are: ( phlorizin; (A) phloretin; (LI) Cyto B: (A) Cyto E.
ture of this transport process is similar to that in the basolateral
membrane of intestinal epithelial cells and plasma membranes
of a variety of non-renal cells such as erythrocytes and adi-
pocytes [2, 5—12]. Cytochalasin B is a fungal metabolite that
inhibits Na -independent D-glucose transport in erythrocytes
and adipocytes. Transport inhibition is though to be related to
binding of cytochalasin B to the D-glucose transporter itself or
to a component of the transporter [5—121. Binding of cytocha-
lasin B to canine renal proximal tubular basolateral membranes
has been reported in a preliminary communication [12]. In the
present studies, cytochalasin B binding to rabbit renal proximal
tubular basolateral membranes is more extensively character-
ized with respect to kinetics, inhibitor sensitivity and D-glucose
analogue specificity.
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Fig. 2. Scatchardplot of[HJcytochalasin B
binding to basolateral membranes. Data
represent concentration range from 0.01 to 20
/LM. Data from 3 experiments are pooled.
Inset: 2-site model generated by non-linear
regression of binding data. Kdl = 5.88 x 10
M; B,,,,x1 = 16.1 pmol/mg; Kd2 = 5.62 xM; B2 = 2816 pmol/mg.
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Fig. 5. Effect of hexose analogues on [3HJcyiochalasin B (0.1 zM)
binding to renal basolateral membranes. Data are expressed as mean
SE of 4 experiments.
Table I. Kinetics of cytochalasin B binding of high-affinity site
plasma membranes from various tissues
Tissue
Kd
M
Bm,x
p,nol/mg Reference
Adipocyte, rat 17 >< 108 7.8—24.4 Cushman [171
Adipocyte, rat 61 x 10 28 Czech [91
Adipocyte, rat 11.1 x lO 6.3—24.7 Wardzala [18]
RBC. human 6.6 x lO 178 Wang [19]
RBC, rat 4.5 x 108 12.5 Wang [191
Intestine, rat 8 x l0 8.3 Maenz [II)
Intestine, mouse — 13.6 Uezato [tO]
In several studies, measurements of cytochalasin B binding
to non-renal tissues were performed in the presence of cyto-
chalasin E [11, 16—19]. The assumption is made that cytocha-
lasin E eliminates non-specific binding of cytochalasin B to sites
other than the glucose transporter, However, interactions be-
tween the two cytochalasin compounds with one another and
with membrane receptor sites have never been clearly defined.
Therefore, cytochalasin E was not used in this study as a
blocker. The use of non-linear regression analysis of Scatchard
binding data was adopted instead to account for all possible
binding sites on basolateral membranes.
As is the case in erythrocyte and adipocyte plasma mem-
branes, and enterocyte basolateral membranes, renal proximal
tubular basolateral membranes contain a "high affinity" binding
site for cytochalasin B. As shown in Table 1, the Kd of 5.88 X
10—8 M for high affinity cytochalasin B binding in renal proximal
tubule basolateral membrane is in close agreement with that
reported for binding in plasma membranes from adipocytes,
erythrocytes, and intestinal enterocytes [II, 17—19]. Likewise
our estimated high affinity receptor density of 16.1 pmol/mg
protein is similar to that found in these membranes [9—Il, 17—
19].
Binding of [3H]cytochalasin B to proximal tubular basolateral
membranes is inhibited by phioretin, as is the case in erythro-
cyte, adipocyte and intestinal membranes [7—10]. In addition,
high concentrations (500 mM) of D-glucose, as well as 2-deoxy-
D-glucose and 3-O-methyl-D-glucose, but not L-glucose, inhibit
cytochalasin B binding. Thus hexoses that are substrates for the
basolateral Nat-independent D-glucose transporter also inhibit
cytochalasin B binding [4]. It should be noted that as was the
case in studies that employed non-renal membranes [6, 11, 18,
201, concentrations of D-glucose far in excess of the Km for
transport were required to inhibit cytochalasin B binding.
Both 2-deoxy-D-glucose and 3-O-methyl-D-glucose are more
inhibitory to cytochalasin B binding in basolateral membranes
than is D-glucose itself. This is in contrast to our previous
findings that trans-stimulated uptake of D-['4C]glucose into
basolateral membrane vesicles by D-glucose is greater than that
by either 2-deoxy-D-glucose or 3-O-methyl-D-glucose [4]. Sim-
ilar observations were noted in human erythrocyte membranes
in which 2-deoxy-D-glucose and 3-O-methyl-D-glucose were
more inhibitory to cytochalasin B binding than D-glucose [20],
while transport studies revealed that 3-O-methyl-D-glucose had
a lower affinity for the transporter than did D-glucose [21]. In
rat intestinal basolateral membranes, 2-deoxy-D-glucose as well
as D-xylose and D-mannose were more inhibitory to cytocha-
lasin B binding than D-glucose [10]. This is in distinction to
stereospecific D-['4C]glucose transport where D-glucose was as
inhibitory as 2-deoxy-D-glucose and was more inhibitory than
D-mannose and D-xylose [221. The lack of effect of L-glucose
on cytochalasin B binding reflects the absence of an effect on
D-glucose transport reported by us and others [1, 4].
Our observations are consistent with the identity of the
high-affinity cytochalasin B binding site in renal proximal tubu-
lar basolateral membranes as the Na4-independent D-glucose
transporter or a component of the transporter. These data
suggest that the Na-independent D-glucose transporter of the
renal proximal tubular cell has structural similarity to glucose
transporters of non-renal cells. Such a conclusion is consistent
with the findings of Mueckler et al who showed that human
kidney cortex and medulla contain messenger RNA species
homologous to Nat-independent glucose transporter messen-
ger RNA obtained from a human hepatoma cell line [23].
Measurement of cytochalasin B binding to the high affinity site
of proximal tubular basolateral membranes should provide a
useful marker of D-glucose transport activity at this site.
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